Literature DB >> 6086189

Preferential generation of leukotriene C4 by human eosinophils.

R J Shaw, O Cromwell, A B Kay.   

Abstract

The leukotriene generating capacities of ionophore stimulated human eosinophils and neutrophils were compared using specific radioimmunoassays for LTB4 and LTC4. Mixed granulocyte preparations (neutrophils and eosinophils) produced both LTB4 and LTC4 in a time-dependent fashion which was maximal at 10 and 15 min, respectively. Following the separation of eosinophils (greater than 75%) and neutrophils (greater than 90%) by metrizamide gradients, LTC4 production was predominantly from eosinophils, whereas neutrophils were the principal source of LTB4. The concentrations of leukotrienes produced by the eosinophil and neutrophil rich cell preparations were directly proportional to the concentration of ionophore. Following purification of eosinophil derived products by RP-HPLC the LTC4 immunoreactivity corresponded to the elution profile of a synthetic LTC4 marker. Furthermore, in 32 atopic subjects (21 bronchial asthmatics and 11 non-asthmatics) the amounts of LTC4 produced by unseparated leucocytes were directly proportional to the percentage of eosinophils in the total cell suspension. Preferential generation of LTB4 by neutrophils was also demonstrated by immunoreactivity of ionophore stimulated supernatants subjected to RP-HPLC, as well as by its characteristic u.v. absorbance and GC-MS profile and the ability to promote directional neutrophil locomotion (chemotaxis). These experiments support the concept that eosinophils accumulate in tissues partly as a result of the response to neutrophil derived LTB4, and that these cells contribute to the production of sulphidopeptide leukotrienes with subsequent amplification of the acute allergic response.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086189      PMCID: PMC1536005     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni.

Authors:  M A Vadas; J R David; A Butterworth; N T Pisani; T A Siongok
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

2.  Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro.

Authors:  C J Hanna; M K Bach; P D Pare; R R Schellenberg
Journal:  Nature       Date:  1981-03-26       Impact factor: 49.962

3.  Histamine metabolism. II. Cellular and subcellular localization of the catabolic enzymes, histaminase and histamine methyl transferase, in human leukocytes.

Authors:  R S Zeiger; D L Yurdin; H R Colten
Journal:  J Allergy Clin Immunol       Date:  1976-07       Impact factor: 10.793

4.  Bronchoconstrictor effects of leukotriene C in humans.

Authors:  J W Weiss; J M Drazen; N Coles; E R McFadden; P F Weller; E J Corey; R A Lewis; K F Austen
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

5.  Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma.

Authors:  T H Lee; L Nagy; T Nagakura; M J Walport; A B Kay
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

6.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.

Authors:  A W Ford-Hutchinson; M A Bray; M V Doig; M E Shipley; M J Smith
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

7.  Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products.

Authors:  L Nagy; T H Lee; E J Goetzl; W C Pickett; A B Kay
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

8.  Role of the eosinophil in the allergic reactions. I. EDI-an eosinophil-derived inhibitor of histamine release.

Authors:  T Hubscher
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

9.  Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4.

Authors:  R D Camp; A A Coutts; M W Greaves; A B Kay; M J Walport
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

10.  Leukotriene generation by eosinophils.

Authors:  A Jörg; W R Henderson; R C Murphy; S J Klebanoff
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Leukotriene A4 hydrolase and the committed step in leukotriene B4 biosynthesis.

Authors:  J Z Haeggström
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  Leukocyte activation following IgE dependent mechanisms in bronchial asthma.

Authors:  S R Durham
Journal:  Clin Rev Allergy       Date:  1989

3.  Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.

Authors:  W F Owen; J Petersen; K F Austen
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects.

Authors:  A P Sampson; R U Thomas; J F Costello; P J Piper
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

Review 5.  What is the role of the eosinophil?

Authors:  P Venge
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

6.  Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni.

Authors:  R Moqbel; A J Macdonald; O Cromwell; A B Kay
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

7.  The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils.

Authors:  P Fitzharris; R Moqbel; K J Thorne; B A Richardson; A Hartnell; O Cromwell; A E Butterworth; A B Kay
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

Review 8.  Eosinophils as effector cells in immunity and hypersensitivity disorders.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

9.  Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.

Authors:  S R White; M E Strek; G V Kulp; S M Spaethe; R A Burch; S P Neeley; A R Leff
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  Blood eosinophils, leukotriene C4 generation, and bronchial hyperreactivity in formerly preterm infants.

Authors:  U Schauer; S Alefsen; R Jäger; F Riedel; C H Rieger
Journal:  Arch Dis Child       Date:  1994-12       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.